Manulife (Manufacturers Life Insurance)’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-74,708
| Closed | -$9.58M | – | 2914 |
|
|
2025
Q2 | $9.58M | Sell |
74,708
-89,347
| -54% | -$9.28M | 0.01% | 861 |
|
|
2025
Q1 | $14.5M | Sell |
164,055
-12,429
| -7% | -$1.21M | 0.01% | 694 |
|
|
2024
Q4 | $15.4M | Buy |
176,484
+26,488
| +18% | +$2.43M | 0.01% | 707 |
|
|
2024
Q3 | $13.9M | Sell |
149,996
-18,763
| -11% | -$1.86M | 0.01% | 746 |
|
|
2024
Q2 | $18.2M | Sell |
168,759
-15,461
| -8% | -$1.55M | 0.02% | 639 |
|
|
2024
Q1 | $17.5M | Buy |
184,220
+48,251
| +35% | +$4.14M | 0.02% | 663 |
|
|
2023
Q4 | $12.5M | Buy |
135,969
+4,746
| +4% | +$308K | 0.01% | 764 |
|
|
2023
Q3 | $6.59M | Buy |
131,223
+7,916
| +6% | +$423K | ﹤0.01% | 987 |
|
|
2023
Q2 | $7.79M | Buy |
123,307
+12,084
| +11% | +$657K | ﹤0.01% | 888 |
|
|
2023
Q1 | $5M | Buy |
111,223
+17,725
| +19% | +$798K | ﹤0.01% | 1081 |
|
|
2022
Q4 | $4.04M | Buy |
93,498
+12,356
| +15% | +$593K | ﹤0.01% | 1159 |
|
|
2022
Q3 | $5.34M | Buy |
81,142
+19,290
| +31% | +$1.24M | ﹤0.01% | 1013 |
|
|
2022
Q2 | $3.19M | Sell |
61,852
-1,460
| -2% | -$85.5K | ﹤0.01% | 1293 |
|
|
2022
Q1 | $4.09M | Buy |
63,312
+33,822
| +115% | +$2.43M | ﹤0.01% | 1287 |
|
|
2021
Q4 | $3.2K | Sell |
29,490
-315
| -1% | -$33K | ﹤0.01% | 1376 |
|
|
2021
Q3 | $3.06M | Sell |
29,805
-2,923
| -9% | -$272K | ﹤0.01% | 1392 |
|
|
2021
Q2 | $2.88M | Buy |
32,728
+1,783
| +6% | +$163K | ﹤0.01% | 1476 |
|
|
2021
Q1 | $3.01M | Sell |
30,945
-1,945
| -6% | -$194K | ﹤0.01% | 1425 |
|
|
2020
Q4 | $3.69M | Buy |
32,890
+1,118
| +4% | +$118K | ﹤0.01% | 1337 |
|
|
2020
Q3 | $2.94M | Sell |
31,772
-350
| -1% | -$27K | ﹤0.01% | 1318 |
|
|
2020
Q2 | $2.46M | Sell |
32,122
-1,126
| -3% | -$76.2K | ﹤0.01% | 1350 |
|
|
2020
Q1 | $1.94M | Buy |
33,248
+4,023
| +14% | +$259K | ﹤0.01% | 1304 |
|
|
2019
Q4 | $2.34M | Sell |
29,225
-908
| -3% | -$68K | ﹤0.01% | 1358 |
|
|
2019
Q3 | $2.21M | Sell |
30,133
-2,183
| -7% | -$189K | ﹤0.01% | 1354 |
|
|
2019
Q2 | $3.05M | Buy |
32,316
+5,406
| +20% | +$446K | ﹤0.01% | 1301 |
|
|
2019
Q1 | $2.15M | Buy |
26,910
+1,512
| +6% | +$112K | ﹤0.01% | 1395 |
|
|
2018
Q4 | $1.37M | Sell |
25,398
-1,326
| -5% | -$80.6K | ﹤0.01% | 1465 |
|
|
2018
Q3 | $2.09M | Sell |
26,724
-3,735
| -12% | -$260K | ﹤0.01% | 1451 |
|
|
2018
Q2 | $1.93M | Sell |
30,459
-866
| -3% | -$68.9K | ﹤0.01% | 1510 |
|
|
2018
Q1 | $2.87M | Sell |
31,325
-861
| -3% | -$74.2K | ﹤0.01% | 1385 |
|
|
2017
Q4 | $2.43M | Buy |
32,186
+2,748
| +9% | +$193K | ﹤0.01% | 1414 |
|
|
2017
Q3 | $2.05M | Sell |
29,438
-424
| -1% | -$22.7K | ﹤0.01% | 1425 |
|
|
2017
Q2 | $1.51M | Buy |
29,862
+13,194
| +79% | +$560K | ﹤0.01% | 1580 |
|
|
2017
Q1 | $667K | Buy |
16,668
+2,524
| +18% | +$90.4K | ﹤0.01% | 1990 |
|
|
2016
Q4 | $396K | Sell |
14,144
-57
| -0.4% | -$1.72K | ﹤0.01% | 2269 |
|
|
2016
Q3 | $422K | Sell |
14,201
-210
| -1% | -$5.22K | ﹤0.01% | 2183 |
|
|
2016
Q2 | $292K | Buy |
14,411
+7,199
| +100% | +$131K | ﹤0.01% | 2413 |
|
|
2016
Q1 | $124K | Buy |
7,212
+259
| +4% | +$4.49K | ﹤0.01% | 2933 |
|
|
2015
Q4 | $183 | Buy |
6,953
+169
| +2% | +$3.81K | ﹤0.01% | 2727 |
|
|
2015
Q3 | $145 | Buy |
6,784
+144
| +2% | +$3.98K | ﹤0.01% | 2910 |
|
|
2015
Q2 | $176 | Buy |
+6,640
| New | +$190K | ﹤0.01% | 2960 |
|
Other funds holding BPMC
IA
HNB
Manulife (Manufacturers Life Insurance)'s BPMC Position: Q3 2025 in Review
Manulife (Manufacturers Life Insurance) sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 74,708 shares — an estimated $9.58M sold.
Manulife (Manufacturers Life Insurance) first reported a position in BPMC in Q2 2015 and held it in 41 quarters. The position peaked at $18.2M in Q2 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Manulife (Manufacturers Life Insurance) reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 74,708 Blueprint Medicines shares in Q3 2025, an estimated $9.58M.
- Manulife (Manufacturers Life Insurance) first reported a position in Blueprint Medicines in Q2 2015 and held it in 41 quarters.
- Manulife (Manufacturers Life Insurance)'s Blueprint Medicines position peaked at $18.2M in Q2 2024.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2025, filed 14 Nov 2025.